See "Proton Therapy for Prostate Cancer: the Initial Loma Linda
University Experience" (Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):
348-52; Slater JD, Rossi CJ Jr, Yonemoto LT, Bush DA, Jabola BR, Levy
RP, Grove RI, Preston W, Slater JM). In this paper, the median follow-
up is 62 months and results are statistically projected out to 10
years using standard techniques. Although the results are not
stratified in great detail, they still allow comparison to the
Hopkins' surgical 10-year projections (see M. Han, A. W. Partin, M.
Zahurak, S. Piantadosi, J. Epstein and P. C. Walsh; J. Urol., 169,
517-523, 2003; the paper can be found at
http://www.prostate-help.org/download/jhnomo.pdf). Compare the two
sets of results and draw your own conclusions. A few points to keep
in mind,
1) many of the men in the Loma Linda paper were treated with a mix of
photons and protons
2) the Loma Linda researchers used the ASTRO definition of failure
(DOF) whereas Hopkins used PSA>0.2 ng/ml. At median follow-ups around
5 years, different researchers have found that 10-year recurrence-free
projections comparing the "PSA>0.2 ng/ml" DOF and the ASTRO DOF on the
same underlying population leads to differences in failure rates
ranging from 15-35% with ASTRO being the more forgiving (see for
example, 1) American Society of Therapeutic Radiology and Oncology
consensus definition; J Urol. 2002 Mar;167(3):1310-3; Critz, FA., 2) J
Urol. 2001 Apr;165(4):1146-51; Amling CL, Bergstralh EJ, Blute ML,
Slezak JM, Zincke H).
....ron